America Movil SAB de CV ADR (AMX)vsSanofi ADR (SNY)
AMX
America Movil SAB de CV ADR
$24.76
+4.52%
COMMUNICATION SERVICES · Cap: $70.61B
SNY
Sanofi ADR
$46.03
+1.97%
HEALTHCARE · Cap: $109.03B
Smart Verdict
WallStSmart Research — data-driven comparison
America Movil SAB de CV ADR generates 1920% more annual revenue ($943.64B vs $46.72B). SNY leads profitability with a 16.7% profit margin vs 8.8%. AMX appears more attractively valued with a PEG of 1.17. AMX earns a higher WallStSmart Score of 69/100 (B-).
AMX
Strong Buy69
out of 100
Grade: B-
SNY
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+67.3%
Fair Value
$72.07
Current Price
$24.76
$47.31 discount
Margin of Safety
-89.7%
Fair Value
$24.79
Current Price
$46.03
$21.24 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Generating 42.7B in free cash flow
Large-cap with strong market position
Every $100 of equity generates 21 in profit
Attractively priced relative to earnings
Strong operational efficiency at 20.1%
Reasonable price relative to book value
Large-cap with strong market position
Generating 1.6B in free cash flow
Areas to Watch
3.4% revenue growth
4.0% earnings growth
Trading at 72.8x book value
Distress zone — elevated risk
2.4% earnings growth
ROE of 6.7% — below average capital efficiency
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : AMX
The strongest argument for AMX centers on Free Cash Flow, Market Cap, Return on Equity. PEG of 1.17 suggests the stock is reasonably priced for its growth.
Bull Case : SNY
The strongest argument for SNY centers on Price/Book, Market Cap, Free Cash Flow. Profitability is solid with margins at 16.7% and operating margin at 14.3%.
Bear Case : AMX
The primary concerns for AMX are Revenue Growth, EPS Growth, Price/Book. Debt-to-equity of 2.53 is elevated, increasing financial risk.
Bear Case : SNY
The primary concerns for SNY are EPS Growth, Return on Equity, PEG Ratio.
Key Dynamics to Monitor
AMX profiles as a value stock while SNY is a mature play — different risk/reward profiles.
AMX carries more volatility with a beta of 0.37 — expect wider price swings.
SNY is growing revenue faster at 6.9% — sustainability is the question.
AMX generates stronger free cash flow (42.7B), providing more financial flexibility.
Bottom Line
AMX scores higher overall (69/100 vs 49/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
America Movil SAB de CV ADR
COMMUNICATION SERVICES · TELECOM SERVICES · USA
Amrica Mvil, SAB de CV provides telecommunications services in Latin America and internationally. The company is headquartered in Mexico City, Mexico.
Visit Website →Sanofi ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Compare with Other TELECOM SERVICES Stocks
Want to dig deeper into these stocks?